Shalini Gidwani

Shalini Gidwani has extensive work experience in the field of regulatory affairs. Shalini is currently the Senior Vice President of Global Regulatory Affairs at Allogene Therapeutics, a position they have held since January 2023. Prior to this role, they served as the Vice President and Head of Regulatory Affairs at Allogene Therapeutics from December 2018 to January 2023.

Before joining Allogene Therapeutics, Shalini worked at Abbvie as the Senior Director and Head of Regulatory Affairs from 2017 to 2018. Shalini also gained valuable experience at Gilead Sciences, where they held the position of Director of Global Regulatory Leader from 2008 to 2017.

Shalini's career in regulatory affairs began at Regulatory Affairs-ALZA/JNJ, where they were an Associate Director from 2006 to 2008. Prior to that, they worked at JNJ as an Associate Director in the field of BA/DMPK from 1998 to 2006.

Their earlier experience includes working as a Development Scientist/Team Lead at Systemix (Novartis) from 1993 to 1998 and as a Development Scientist at Genentech from 1989 to 1993.

Overall, Shalini Gidwani has a long and varied career in regulatory affairs, with expertise in leading regulatory teams and ensuring compliance with global regulatory requirements.

Shalini Gidwani holds a Master of Science degree in Biochemistry from M.S University, Baroda. No specific information regarding the start and end years of their education at this institution is provided.